Narrative review: Diseases that masquerade as infectious cellulitis

Annals of Internal Medicine

Volumn 142, Issue 1, 2005, Pages 47-55

  Falagas, Matthew E ^a   Vergidis, Paschalis I ^b  

^a Alfa HealthCare   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; COLCHICINE; CORTICOSTEROID; COTRIMOXAZOLE; DOXEPIN; HEPARIN; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; STANOZOLOL;

ANGIONEUROTIC EDEMA; ANTIBIOTIC THERAPY; BREAST CARCINOMA; CALCINOSIS; CARCINOMA ERYSIPELATOIDES; CELLULITIS; COMPARTMENT SYNDROME; COMPRESSION THERAPY; CONTACT DERMATITIS; CORTICOSTEROID THERAPY; DEBRIDEMENT; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; ENVENOMATION; ERYTHEMA NODOSUM; ERYTHROMELALGIA; FAMILIAL MEDITERRANEAN FEVER; FASCIOTOMY; FOREIGN BODY; GLUCAGONOMA; GOUT; HUMAN; INFECTION; INSECT STING; LEUKEMIA; LIPODERMATOSCLEROSIS; LUPUS ERYTHEMATOSUS; LYMPHEDEMA; LYMPHOMA; MORPHEA; PAGET NIPPLE DISEASE; PAGET SKIN DISEASE; PANNICULITIS; PARATHYROIDECTOMY; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RASH; RELAPSING POLYCHONDRITIS; REVIEW; SARCOIDOSIS; SKIN METASTASIS; THROMBOPHLEBITIS; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; URTICARIA; VIRUS HEPATITIS; WELLS SYNDROME;

EID: 11244310523     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-1-200501040-00011     Document Type: Review

References (126)

1. Tagalakis V, Kahn SR, Libman M, Blostein M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med. 2002;113:146-51. [PMID: 12133753]
2. Ascher E, Hanson JN, Salles-Cunha S, Hingorani A. Lesser saphenous vein thrombophlebitis: its natural history and implications for management. Vasc Endovascular Surg. 2003;37:421-7. [PMID: 14671697]
3. Raake W, Binder M. [Treatment of superficial thrombophlebitis]. Hamostaseologie. 2002;22:149-53. [PMID: 12540973]
4. Siegelman ES, Needleman L. Venous thrombosis and cancer [Letter]. N Engl J Med. 1993;328:885; author reply 886-7. [PMID: 8373456]
5. Kennedy D, Setnik G, Li J. Physical examination findings in deep venous thrombosis. Emerg Med Clin North Am. 2001;19:869-76. [PMID: 11762276]
6. Baker WF Jr. Diagnosis of deep venous thrombosis and pulmonary embolism. Med Clin North Am. 1998;82:459-76. [PMID: 9646774]
7. Frazee BW, Snoey ER. Diagnostic role of ED ultrasound in deep venous thrombosis and pulmonary embolism. Am J Emerg Med. 1999;17:271-8. [PMID: 10337888]
8. Baker WF Jr. Diagnosis of deep venous thrombosis and pulmonary embolism. Med Clin North Am. 1998;82:459-76. [PMID: 9646774]
9. Frazee BW, Snoey ER. Diagnostic role of ED ultrasound in deep venous thrombosis and pulmonary embolism. Am J Emerg Med. 1999;17:271-8. [PMID: 10337888]
10. Ramzi DW, Leeper KV. DVT and pulmonary embolism: Part II. Treatment and prevention. Am Fam Physician. 2004;69:2841-8. [PMID: 15222649]
11. Erdmann SM, Merk HF. [Contact sensitization to external agents]. Hautarzt. 2003;54:331-7. [PMID: 12669204]
12. Antezana M, Parker F. Occupational contact dermatitis. Immunol Allergy Clin North Am. 2003;23:269-90, vii. [PMID: 12803363]
13. Fonacier L, Charlesworth EN. Patch testing for allergic contact dermatitis in the allergist office. Curr Allergy Asthma Rep. 2003;3:283-90. [PMID: 12791205]
14. Levin C, Maibach HI. An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis. Contact Dermatitis. 2000;43: 317-21. [PMID: 11140380]
15. Martin BG. Contact dermatitis: evaluation and treatment. J Am Osteopath Assoc. 1999;99:S11-4. [PMID: 10217916]
16. Brook I. Secondary bacterial infections complicating skin lesions. J Med Microbiol. 2002;51:808-12. [PMID: 12435058]
17. Reisman RE. Insect stings. N Engl J Med. 1994;331:523-7. [PMID: 8041420]
18. Green AW, Reisman RE, Arbesman CE. Clinical and immunologic studies of patients with large local reactions following insect stings. J Allergy Clin Immunol. 1980;66:186-9. [PMID: 7410742]
19. Stawiski MA, Insect bites and stings. Emerg Med Clin North Am. 1985;3: 785-808. [PMID: 2414093]
20. Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol. 1998;37:833-8. [PMID: 9865869]
21. Ozkaya-Bayazit E. Specific site involvement in fixed drug eruption. J Am Acad Dermatol. 2003;49:1003-7. [PMID: 14639376]
22. Ozkaya-Bayazit E, Bayazit H, Ozarmagan G. Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption. Contact Dermatitis. 1999; 41:185-9. [PMID: 10515095]
23. Alanko K. Topical provocation of fixed drug eruption. A study of 30 patients. Contact Dermatitis. 1994;31:25-7. [PMID: 7924289]
24. Moossavi M, Mehregan DR. Wells' syndrome: a clinical and histopathologic review of seven cases. Int J Dermatol. 2003;42:62-7. [PMID: 12581147]
25. Weiss G, Shemer A, Confino Y, Kaplan B, Trau H. Wells' syndrome: report of a case and review of the literature. Int J Dermatol. 2001;40:148-52. [PMID: 11328401]
26. Bogenrieder T, Griese DP, Schiffner R, Büttner R, Riegger GA, Hohenleutner U, et al. Wells' syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol. 1997;137:978-82. [PMID: 9470919]
27. Ludwig RJ, Grundmann-Kollmann M, Holtmeier W, Wolter M, Glas J, Podda M, et al. Herpes simplex virus type 2-associated eosinophilic cellulitis (Wells' syndrome). J Am Acad Dermatol. 2003;48:S60-1. [PMID: 12734477]
28. Secßkin D, Demirhan B. Drugs and Wells' syndrome: a possible causal relationship? Int J Dermatol. 2001;40:138-40. [PMID: 11328398]
29. Weiss G, Shemer A, Confino Y, Kaplan B, Trau H. Wells' syndrome: report of a case and review of the literature. Int J Dermatol. 2001;40:148-52. [PMID: 11328401]
30. Burrall B. Sweet's syndrome (acute febrile neutrophilic dermatosis). Dermatol Online J. 1999;5:8. [PMID: 10673451]
31. Cohen PR, Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42:761-78. [PMID: 14521689]
32. Cohen PR, Kurzrock R. Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol. 2002;3:117-31. [PMID: 11893223]
33. Dompmartin A, Troussard X, Lorier E, Jacobs F, Reman O, Leroy D, et al. Sweet syndrome associated with acute myelogenous leukemia. Atypical form simulating facial erysipelas. Int J Dermatol. 1991;30:644-7. [PMID: 1938078]
34. Crum NF, Higginbottom PA, Fehl FC, Graham BS. Sweet's syndrome masquerading as facial cellulitis. Cutis. 2003;71:469-72. [PMID: 12839258]
35. Tercedor J, Ródenas JM, Henraz MT, García-Mellado V, Gutierrez-Salmerón MT, Naranjo R. Facial cellulitis-like Sweet's syndrome in acute myelogenous leukemia [Letter]. Int J Dermatol. 1992;31:598-9. [PMID: 1428459]
36. Cohen JB. Cutaneous involvement of dermatomyositis can respond to Dapsone therapy. Int J Dermatol. 2002;41:182-4. [PMID: 12010348]
37. Siva C, Velazquez C, Mody A, Brasington R. Diagnosing acute monoarthritis in adults: a practical approach for the family physician. Am Fam Physician. 2003;68:83-90. [PMID: 12887114]
38. Swan A, Amer H, Dieppe P. The value of synovial fluid assays in the diagnosis of joint disease: a literature survey. Ann Rheum Dis. 2002;61:493-8. [PMID: 12006320]
39. Terkeltaub RA. Clinical practice. Gout. N Engl J Med. 2003;349:1647-55. [PMID: 14573737]
40. Kurzrock R, Cohen PR. Erythromelalgia: review of clinical characteristics and pathophysiology. Am J Med. 1991;91:416-22. [PMID: 1951386]
41. Michiels JJ. Erythromelalgia and vascular complications in polycythemia vera. Semin Thromb Hemost. 1997;23:441-54. [PMID: 9387203]
42. McCarthy L, Eichelberger L, Skipworth E, Danielson C. Erythromelalgia due to essential thrombocythemia. Transfusion. 2002;42:1245. [PMID: 12423504]
43. Davis MD, O'Fallon WM, Rogers RS 3rd, Rooke TW. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000;136:330-6. [PMID: 10724194]
44. Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS. Relapsing polychondritis: a clinical review. Semin Arthritis Rheum. 2002;31:384-95. [PMID: 12077711]
45. Coppola M, Yealy DM. Relapsing polychondritis: an unusual cause of painful auricular swelling. Ann Emerg Med. 1992;21:81-5. [PMID: 1539895]
46. Khan AJ, Lynfield Y, Baldwin H. Relapsing polychohdritis: case report and review of the literature. Cutis. 1994;54:98-100. [PMID: 7956342]
47. Soto-Romero I, Fustes-Morales AJ, De Leon-Bojorge B, Contreras-Ruiz J, Ruiz-Maldonado R. Relapsing polychondritis: a pediatric case. Pediatr Dermatol. 2002;19:60-3. [PMID: 11860574]
48. Khan JH, Ahmed I. A case of relapsing polychondritis involving the tragal and the conchal bowl areas with sparing of the helix and the antihelix. J Am Acad Dermatol. 1999;41:299-302. [PMID: 10426914]
49. Khan AJ, Lynfield Y, Baldwin H. Relapsing polychondritis: case report and review of the literature. Cutis. 1994;54:98-100. [PMID: 7956342]
50. Copeman PW, Farthing CF, Leader M. Cutaneous metastasis (cancer en cuitasse and carcinoma erysipelatoides): a non-invasive search for the primary cancer using microscopical techniques on urine and skin. J R Soc Med. 1985;78 Suppl 11:43-5. [PMID: 3005564]
51. Hazelrigg DE, Rudolph AH. Inflammatory metastic carcinoma. Carcinoma erysipelatoides. Arch Dermatol. 1977;113:69-70. [PMID: 831626]
52. Langevitz P, Livneh A, Padeh S, Zaks N, Shinar Y, Zemer D, et al. Familial Mediterranean fever: new aspects and prospects at the end of the millenium. Isr Med Assoc J. 1999;1:31-6. [PMID: 11370119]
53. Majeed HA, Quabazard Z, Hijazi Z, Farwana S, Harshani F. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study. Q J Med. 1990;75:607-16. [PMID: 2217666]
54. Barzilai A, Langevitz P, Goldberg I, Kopolovic J, Livneh A, Pras M, et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol. 2000;42:791-5. [PMID: 10775856]
55. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med. 1974;291:934-7. [PMID: 4606353]
56. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med. 1974;291:932-4. [PMID: 4606109]
57. Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ. Familial Hibernian fever. Q J Med. 1982;51:469-80. [PMID: 7156325]
58. McDermott EM, Smillie DM, Powell RJ. Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc. 1997;72:806-17. [PMID: 9294526]
59. Vigan M, Girardin P, Adessi B, Laurent R. [Cutaneous reactions to orthopedic implants]. Ann Dermatol Venereol. 1996;123:686-90. [PMID: 9615136]
60. Falagas ME, Kasiakou SK. [Mesh-related infections after hernia repair surgery.] Clinical Microbiology and Infection. [In press].
61. Klosterhalfen B, Hermanns B, Rosch R, Junge K. [Biological response to mesh.]. European Surgery. 2003;35:16-20.
62. Fitzpatrick BT. Urticaria and angioedema. In: Fitzpatrick BT, Johnson RA, Wolff K, Suurrnond D, eds. Color Atlas and Synopsis of Clinical Dermatology: Common and Serious Diseases. 4th ed. New York: McGraw-Hill; 2000.
63. Ledo A, Harto A, Sendagorta E. Doxepin in the treatment of chronic urticaria [Letter]. J Am Acad Dermatol. 1985;13:1058-9. [PMID: 4078098]
64. Chicarilli ZN. Follicular occlusion triad: hidradenitis suppurativa, acne conglobata, and dissecting cellulitis of the scalp. Ann Plast Surg. 1987;18:230-7. [PMID: 2954503]
65. Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol Online J. 2003;9:8. [PMID: 12639466]
66. Schewach-Millet M, Ziv R, Shapira D. Perifolliculitis capitis abscedens et suffodiens treated with isotretinoin (13-cis-retinoic acid) [Letter]. J Am Acad Dermatol. 1986;15:1291-2. [PMID: 3468134]
67. Shaffer N, Billick RC, Srolovitz H. Perifolliculitis capitis abscedens et suffodiens. Resolution with combination therapy. Arch Dermarol. 1992;128:1329-31. [PMID: 1417019]
68. Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med. 1998;3:145-56. [PMID: 9796078]
69. Witte CL, Witte MH, Unger EC, Williams WH, Bernas MJ, McNeill GC, et al. Advances in imaging of lymph flow disorders. Radiographics. 2000;20: 1697-719. [PMID: 11112825]
70. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology. 2003;36:84-91. [PMID: 12926833]s
71. Loprinzi CL, Okuno Sh, Pisansky TM, Sterioff S, Gaffey TA, Morton RF. Postsurgical changes of the breast that mimic inflammatory breast carcinoma. Mayo Clin Proc. 1996;71:552-5. [PMID: 8642883]
72. King R, Duncan L, Shupp DL, Googe PB. Postsurgical dermal lymphedema clinically mimicking inflammatory breast carcinoma [Letter]. Arch Dermatol. 2001;137:969-70. [PMID: 11453830]
73. Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol. 2003;4:449-65. [PMID: 12814335]
74. Patel P, Werth V. Cutaneous lupus erythematosus: a review. Dermatol Clin. 2002;20:373-85, v. [PMID: 12170873]
75. Callen JP. Management of skin disease in patients with lupus eryzhematosus. Best Pract Res Clin Rheumatol. 2002;16:245-64. [PMID: 12041952]
76. Wozniacka A, Carter A, McCauliffe DP. Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit. Lupus. 2002;11:71-81. [PMID: 11958581]
77. Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol. 2003;4:449-65. [PMID: 12814335]
78. Young RJ 3rd, Gilson RT, Yanase D, Elston DM. Cutaneous sarcoidosis. Int J Dermatol. 2001;40:249-53. [PMID: 11454079]
79. Katta R. Cutaneous sarcoidosis: a dermatologic masquerader. Am Fam Physician. 2002;65:1581-4. [PMID: 11989634]
80. Russo G, Millikan LE. Cutaneous sarcoidosis: diagnosis and treatment. Compr Ther. 1994;20:418-21. [PMID: 7924231]
81. Hughes LB, Bridges SL Jr. Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations. Curr Rheumatol Rep. 2002;4:75-82. [PMID: 11798986]
82. Gushi A, Hashiguchi T, Fukumaru K, Usuki K, Kanekura T, Kanzaki T. Three cases of polyarteritis nodosa cutanea and a review of the literature. J Dermatol. 2000;27:778-81. [PMID: 11211794]
83. Chen KR. Cutaneous polyarteritis nodosa: a clinical and histopathological study of 20 cases. J Dermatol. 1989;16:429-42. [PMID: 2576427]
84. Guillevin L, Lhote F. Treatment of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum. 1998;41:2100-5. [PMID: 9870866]
85. Erhardt A, Sagir A, Guillevin L, Neuen-Jacob E, Häussinger D. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine. J Hepatol. 2000;33:677-83. [PMID: 11059878]
86. Requena L, Requena C. Erythema nodosum. Dermatol Online J. 2002;8:4. [PMID: 12165214]
87. Psychos DN, Voulgari PV, Skopouli FN, Drosos AA, Moutsopoulos HM. Erythema nodosum: the underlying conditions. Clin Rheumatol. 2000;19:212-6. [PMID: 10870657]
88. O'Neill JH Jr. The differential diagnosis of erythema nodosum. Del Med J. 1991;63:683-9. [PMID: 1786841]
89. Hassink RI, Pasquinelli-Egli CE, Jacomella V, Laux-End R, Bianchetti MG. Conditions currently associated with erythema nodosum in Swiss children. Eur J Pediatr. 1997;156:851-3. [PMID: 9392398]
90. Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R. Erythema nodosum: an experience of 10 years. Scand J Infect Dis. 2004;36:424-7. [PMID: 15307561]
91. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosderosis. J Am Acad Dermatol. 1993;28:623-7. [PMID: 8463465]
92. Naschitz JE, Yeshurun D, Schwartz H, Croitoru S, Shajrawi I, Misselevich I, et al. Pathogenesis of lipodermatosclerosis of venous disease: the lesson learned from eosinophilic fasciitis. Cardiovasc Surg. 1993;1:524-9. [PMID: 8076090]
93. Gniadecka M, Karlsmark T, Bertram A. Removal of dermal edema with class I and II compression stockings in patients with lipodermatosderosis. J Am Acad Dermatol. 1998;39:966-70. [PMID: 9843010]
94. Bruce AJ, Bennett DD, Lohse CM, Rooke TW, Davis MD. Lipodermatosclerosis: review of cases evaluated at Mayo Clinic. J Am Acad Dermatol. 2002; 46:187-92. [PMID: 11807428]
95. Sehgal VN, Srivastava G, Aggarwal AK, Behl PN, Choudhary M, Bajaj P. Localized scleroderma/morphea. Int J Dermatol. 2002;41:467-75. [PMID: 12207760]
96. Falanga V, Medsger TA Jr. D-penicillamine in the treatment of localized scleroderma. Arch Dermatol. 1990;126:609-12. [PMID: 2334179]
97. Falagas ME, Christopoulou M, Rosmarakis ES, Vlastou C. Munchausen's syndrome presenting as severe panniculitis. Int J Clin Pract. 2004;58:720-2. [PMID: 15311731]
98. Carrasco L, Moreno C, Pastor MA, Izquierdo MJ, Fariña C, Martín L, et al. Postirradiation pseudosclerodermatous panniculitis. Am J Dermatopathol. 2001;23:283-7. [PMID: 11481517]
99. Winkelmann RK, Grado GL, Quimby SR, Connolly SM. Pseudosclerodermatous panniculitis after irradiation: an unusual complication of megavoltage treatment of breast carcinoma. Mayo Clin Proc. 1993;68:122-7. [PMID: 8423691]
100. Preiss JC, Faiss S, Loddenkemper C, Zeitz M, Duchmann R. Pancreatic panniculitis in an 88-year-old man with neuroendocrine carcinoma. Digestion. 2002;66:193-6. [PMID: 12481166]
101. Peters MS, Su WP. Lupus erythematosus panniculitis. Med Clin North Am. 1989;73:1113-26. [PMID: 2671535]
102. Martens PB, Moder KG, Ahmed I. Lupus panniculitis: clinical perspectives from a case series. J Rheumatol. 1999;26:68-72. [PMID: 9918242]
103. McBean J, Sable A, Maude J, Robinson-Bostom L. Alphal-antitrypsin deficiency panniculitis. Cutis. 2003;71:205-9. [PMID: 12661748]
104. Kjus T, Lützow-Holm C, Christensen OB. Treatment of panniculitis associated with alpha-1-antitrypsin deficiency with alpha-1-protease inhibitor [Letter]. Acta Derm Venereol. 2003;83:462-3. [PMID: 14690345]
105. Watabe H, Kawakami T, Soma Y, Baba T, Mizoguchi M. Primary cutaneous T-cell-rich B-cell lymphoma in a zosteriform distribution associated with Epstein-Barr virus infection. J Dermatol. 2002;29:748-53. [PMID: 12484440]
106. Cavalli F. Rare syndromes in Hodgkin's disease. Ann Oncol. 1998;9 Suppl 5:S109-13. [PMID: 9926248]
107. Baddour LM, Haden KH, Allen JW. Primary skeletal muscle lymphoma presenting as refractory cellulitis. Cutis. 2001;68:223-6. [PMID: 11579790]
108. Russell-Jones R, Whittaker S. Sézary syndrome: diagnostic criteria and therapeutic options. Semin Cutan Med Surg. 2000;19:100-8. [PMID: 10892711]
109. Sheahan P, Donnelly M, O'Reilly S, Murphy M. T/NK cell non-Hodgkin's lymphoma of the sinonasal tract. J Laryngol Otol. 2001;115:1032-5. [PMID: 11779343]
110. Kacinski BM, Flick M. Apoptosis and cutaneous T cell lymphoma. Ann N Y Acad Sci. 2001;941:194-9. [PMID: 11594573]
111. Mallett RB, Matutes E, Catovsky D, Madennan K, Mortimer PS, Holden CA. Cutaneous infiltration in T-cell prolymphocytic leukaemia. Br J Dermatol. 1995;132:263-6. [PMID: 7888364]
112. Serra A, Estrach MT, Martí R, Villamor N, Rafel M, Montserrat E. Cutaneous involvement as the first manifestation in a case of T-cell prolymphocytic leukaemia. Acta Derm Venereol. 1998;78:198-200. [PMID: 9602226]
113. Yim JH, Wick MR, Philpott GW, Norton JA, Doherty GM. Underlying pathology in mammary Paget's disease. Ann Surg Oncol. 1997;4:287-92. [PMID: 9181226]
114. Fu W, Mittel VK, Young SC. Paget disease of the breast: analysis of 41 patients. Am J Clin Oncol. 2001;24:397-400. [PMID: 11474272]
115. Marshall JK, Griffith KA, Haffty BG, Solin LJ, Vicini FA, McCormick B, et al. Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. Cancer. 2003;97:2142-9. [PMID: 12712465]
116. Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C. Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999;180:24-7. [PMID: 9914572]
117. Curtin JP, Rubin SC, Jones WB, Hoskins WJ, Lewis JL Jr. Paget's disease of the vulva. Gynecol Oncol. 1990;39:374-7. [PMID: 2175288]
118. Johnson SM, Smoller BR, Lamps LW, Horn TD. Necrolytic migratory erythema as the only presenting sign of a glucagonoma. J Am Acad Dermatol. 2003;49:325-8. [PMID: 12894090]
119. Alexander EK, Robinson M, Staniec M, Dluhy RG. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome. Clin Endocrinol (Oxf). 2002;57:827-31. [PMID: 12460334]
120. Matthews BD, Smith TI, Kercher KW, Holder WD Jr, Heniford BT. Surgical experience with functioning pancreatic neuroendocrine tumors. Am Surg. 2002;68:660-5; discussion 665-6. [PMID: 12206598]
121. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 2002;61:2210-7. [PMID: 12028462]
122. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial. 2002;15:172-86. [PMID: 12100455]
123. Arch-Ferrer JE, Beenken SW, Rue LW, Bland KI, Diethelm AG. Therapy for calciphylaxis: an outcome analysis. Surgery. 2003;134:941-4; discussion 944-5. [PMID: 14668726]
124. Tiwari A, Haq AI, Myint F, Hamilton G. Acute compartment syndromes. Br J Surg. 2002;89:397-412. [PMID: 11952578]
125. Petit A, Sigal M, Merat R, Pepin E, Couffinhal JC. Pseudoerysipelas resulting from acute anterior tibial compartment syndrome. J Am Acad Dermatol. 1996;34:521-2. [PMID: 8609275]
126. Hope MJ, McQueen MM. Acute compartment syndrome in the absence of fracture. J Orthop Trauma. 2004;18:220-4. [PMID: 15087965]